Ukaeje Onyebuchi C, Roy Sanjit K, Shin Samuel, Raheem Sumiyya, Reyes Cory, Bandyopadhyay Bidhan C
Calcium Signaling Laboratory, Veterans Affairs Medical Center, Research Service, Washington, District of Columbia, USA.
Department of Biomedical Engineering, The Catholic University of America, Washington, District of Columbia, USA.
J Biochem Mol Toxicol. 2025 Feb;39(2):e70145. doi: 10.1002/jbt.70145.
Crystalline nephropathy (CN) is characterized by deposition of microcrystals within the kidney tubular microstructure, specifically in the renal tubular cells. Nephropathic conditions have been observed in kidney stone patients as nephrocalcinosis, resulting from the deposition of calcium phosphate (CaP) microcrystals mainly within the renal tubule. CaP microcrystals trigger nephrotoxicity and cell death leading to acute and chronic kidney disease and in some cases end stage renal disease. Although supersaturation of calcium (Ca)- and phosphate (PO ) ions in the urine was described as a main factor the precise mechanism of cell death by distinguishing the impact of supersaturated solution vs the crystalline substances is unclear. Here we show the differential effect of CaP solution vs preformed crystal (as crystalline CaP) on the nephrotoxicity and the degree and type of cell death using a murine kidney tubular cell line, LLCPK1. We examined the cellular [cell viability, lactate dehydrogenase (LDH) and HO releases and Annexin+ propidium iodide (PI) staining] and molecular events [gene expressions, oxidative and endoplasmic reticular (ER) stress] towards understanding the mechanism of CN. The results of the study demonstrated that CaP in solution exerts injury effect on LLCPK1 cells. The addition of CaP solution showed stronger necrosis than the preformed crystals as shown by PI staining and the releases of LDH and HO. Overall, the results in the study revealed a novel mechanism differentiating the kidney cell injury between the insult mediated by supersaturated CaP solution and preformed CaP crystals.
结晶性肾病(CN)的特征是在肾小管微结构内,特别是在肾小管细胞中存在微晶沉积。在肾结石患者中已观察到肾病情况,表现为肾钙质沉着症,这是由磷酸钙(CaP)微晶主要在肾小管内沉积所致。CaP微晶引发肾毒性和细胞死亡,导致急性和慢性肾病,在某些情况下还会导致终末期肾病。尽管尿液中钙(Ca)和磷酸盐(PO)离子的过饱和被描述为一个主要因素,但通过区分过饱和溶液与结晶物质的影响来明确细胞死亡的确切机制尚不清楚。在此,我们使用小鼠肾小管细胞系LLCPK1,展示了CaP溶液与预制晶体(作为结晶性CaP)对肾毒性以及细胞死亡程度和类型的不同影响。我们检查了细胞[细胞活力、乳酸脱氢酶(LDH)和HO释放以及膜联蛋白 + 碘化丙啶(PI)染色]和分子事件[基因表达、氧化应激和内质网(ER)应激],以了解CN的机制。研究结果表明,溶液中的CaP对LLCPK1细胞具有损伤作用。如PI染色以及LDH和HO释放所示,添加CaP溶液比预制晶体表现出更强的坏死。总体而言,该研究结果揭示了一种区分过饱和CaP溶液介导的损伤与预制CaP晶体介导的损伤之间肾细胞损伤的新机制。